Twenty-two patients with peripheral arterial disease or Buerger's disease staged as Fontaine IIb (n = 7), III (n = 4), or IV (n = 11) were treated with two injections of either 2 mg or 4 mg of HGF plasmid. Here, HGF is linked to peripheral arterial disease.